👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

SoftBank group capital sells lemonade shares for $56 million

Published 12/19/2024, 10:04 AM
© Shutterstock
LMND
-

SoftBank (TYO:9984) Group Capital Ltd, a major shareholder in Lemonade, Inc. (NYSE:LMND), recently sold a significant portion of its holdings in the insurance technology company. According to a Form 4 filing with the Securities and Exchange Commission, the firm sold a total of 1,309,106 shares over two days, December 16 and 17, 2024. The transactions were executed at prices ranging from $43.31 to $46.39 per share, amounting to a total sale value of approximately $56 million. The sale comes amid Lemonade's remarkable performance, with the stock surging over 165% in the past six months, though InvestingPro data shows significant price volatility remains a key characteristic of the stock.

Following these transactions, SoftBank's remaining stake in Lemonade stands at 10,706,278 shares. With Lemonade's current market capitalization of $2.79 billion and negative EBITDA of $186 million in the last twelve months, investors seeking deeper insights can access comprehensive analysis through InvestingPro's detailed research reports. The sales reflect SoftBank's continued adjustment of its investment portfolio, although the firm remains a significant shareholder in Lemonade.

In other recent news, Lemonade Inc (NYSE:LMND). has seen significant financial growth and updated analyst outlooks. The insurance tech company reported a 24% increase in in-force premiums to $889 million, a 17% increase in customer count to 2.3 million, and a 71% year-over-year surge in gross profit to $37 million. Analysts project Lemonade's Q4 2024 in-force premium to be between $940 million to $944 million, and revenue projection to be $144 million to $146 million.

Jefferies raised its price target for Lemonade to $20, while maintaining an underperform rating. JMP Securities, on the other hand, upgraded their price target from $40 to $60, retaining a Market Outperform rating. Piper Sandler increased its price target from $25 to $44, keeping a neutral rating, and BMO Capital raised its price target to $15, also maintaining an underperform rating.

Morgan Stanley (NYSE:MS) upgraded Lemonade's stock rating from Underweight to Equal-weight, following the company's investor day. The company has outlined ambitious growth plans, including a roadmap to longer-term profitability and an estimation to grow its in-force premium to $10 billion in the coming years. These recent developments highlight Lemonade's growth trajectory in the insurance technology sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.